4.6 Article

Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Respiratory System

Pirfenidone in idiopathic pulmonary fibrosis

H. Taniguchi et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Review Medicine, General & Internal

Non-steroid agents for idiopathic pulmonary fibrosis

Paolo Spagnolo et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)

Article Biochemistry & Molecular Biology

Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge

Atsushi Hirano et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)

Article Medicine, General & Internal

The clinical course of patients with idiopathic pulmonary fibrosis

FJ Martinez et al.

ANNALS OF INTERNAL MEDICINE (2005)

Article Critical Care Medicine

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

A Azuma et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

Article Pharmacology & Pharmacy

A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level

H Nakazato et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2002)